Assessment of Ocriplasmin Effects on the Vitreoretinal Compartment in Porcine and Human Model Systems
Ocriplasmin (Jetrea®) is a recombinant protease used to treat vitreomacular traction. To gain insight into vitreoretinal observations reported after ocriplasmin treatment, we have developed an in vivo porcine ocriplasmin-induced posterior vitreous detachment (PVD) model in which we investigated vitr...
Saved in:
Main Authors: | Bart Jonckx, Michael Porcu, Aurelie Candi, Isabelle Etienne, Philippe Barbeaux, Jean H. M. Feyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/2060765 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Vitreoretinal Interface Disorders
by: Irini Chatziralli, et al.
Published: (2017-01-01) -
Diagnosis of Vitreoretinal Aspergillosis with Transvitreal Retinochoroidal Biopsy
by: Krishi Peddada, et al.
Published: (2018-01-01) -
Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases
by: Muneo Yamaguchi, et al.
Published: (2017-01-01) -
The International Vitreoretinal B-Cell Lymphoma Registry: a protocol paper
by: David J Wilson, et al.
Published: (2022-07-01) -
The Prevalence and Distribution of Vitreoretinal Interface Abnormalities among Urban Community Population in China
by: Lei Liu, et al.
Published: (2015-01-01)